Quantcast
Last updated on April 21, 2014 at 9:11 EDT

Latest Office for Human Research Protections Stories

2013-09-17 23:27:26

Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, will speak at the 2013 Global Clinical Research Summit to be held Oct. 1 and 2 in Daegu, South Korea. Seattle, WA (PRWEB) September 17, 2013 Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, will speak at the 2013 Global Clinical Research Summit to be held Oct. 1 and 2 in Daegu, South Korea. This...

2013-09-03 12:26:15

WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ -- Elyse I. Summers, J.D., director, Division of Education and Development, at the federal Office for Human Research Protections has been named president and CEO of the Association for the Accreditation of Human Research Protection Programs, effective October 14, 2013. (Logo: http://photos.prnewswire.com/prnh/20130625/NY37243LOGO) The AAHRPP Board of Directors announced the appointment today, citing Summers' more than 14 years of...

2013-08-09 08:25:38

NEW YORK, Aug. 9, 2013 /PRNewswire/ -- Ohr Pharmaceutical (NasdaqCM: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that Dr. Irach Taraporewala, Chief Executive Officer, will present a corporate overview and business update at the Wedbush Life Sciences Management Access Conference at Le Parker Meridien Hotel on August 14(th) in New York City. Details of the presentation are as follows: Date: Wednesday,...

2013-07-18 23:26:08

Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, has been appointed to the Secretary’s Advisory Committee on Human Research Protections (SACHRP). This exclusive panel is selected from the best minds in the research industry to advise the Secretary of Health and Human Services in the area of human research subjects. Seattle, WA (PRWEB) July 18, 2013 Quorum Review IRB, the industry leader in central IRB services,...

2013-05-29 12:27:33

NEW YORK, May 29, 2013 /PRNewswire/ -- Ohr Pharmaceutical (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that Dr. Irach Taraporewala, CEO, will present a corporate overview and business update at the second annual Marcum MicroCap Conference on Thursday, May 30, 2013 at 11:00 am ET. The Conference is being held at the Grand Hyatt Hotel in New York City. Details of the presentation are as follows:Date:...

2013-04-12 23:04:06

The Office for Human Research Protections has noted that several prominent universities failed to tell more than one-thousand families participating in a government-backed oxygen level study that their premature babies were facing an increased risk for blindness or death, according to a New York Times report. The consent form that parents had to sign only warned that there was a potential for skin abrasions caused by the attaching of the devices, as well as a potential benefit of a baby not...

2012-10-05 02:23:44

NEW YORK, Oct. 5, 2012 /PRNewswire/ -- Ohr Pharmaceutical (OTCBB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, announced today that Dr. Irach Taraporewala, Chief Executive Officer of Ohr Pharmaceutical, will be presenting at the 11(th) annual BIO Investor Forum taking place at The Palace Hotel in San Francisco on October 9-10, 2012. Dr. Taraporewala's presentation will include an overview of Ohr's clinical wet-AMD eye drop...

2012-01-18 08:30:00

CAMBRIDGE, Mass., Jan. 18, 2012 /PRNewswire/ -- At universities, hospital systems and government agencies large and small, ethics review boards tasked with overseeing the protection of human subjects in research are actively working to improve the timeliness, accuracy, and quality of reviews and research oversight. These Institutional Review Boards (IRBs) are under tremendous obligation from federal regulation and face intense pressure from medical device and drug companies...

2011-10-26 16:38:00

LAS VEGAS, Oct. 26, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today its Senior Scientific Director, Dr. Jere M. Boyer, Ph.D., will co-present a panel titled Battle of Compliance: FDA vs. OHRP vs. ICH at the MAGI West Clinical Research Conference, October 23-26, 2011 in Las Vegas, NV. The panel will discuss the important...

2006-03-14 09:05:00

By Susan Heavey WASHINGTON -- A top U.S. lawmaker on Monday called on the Food and Drug Administration to publicly explain benefits of an experimental blood substitute after government advisors said a clinical trial for the product was unethical and never should have been approved. The Office for Human Research Protections raised concerns about Northfield Laboratories Inc's PolyHeme as early as June 2004, but the FDA failed to respond, Senate Finance Committee Chairman Charles Grassley said....